Metraipolis › archive › dc_4bbb373f9896

Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease — Europe PMC PMID:41990093

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41990093
DOI
10.1371/journal.pone.0346878
License (as archived)
solo-consultazione
Archived
2026-10-07T14:12:44.483Z
SHA-256 of the archived text
954f2490f35448aa8e46882f0b3ba1fc5a104584c4d93dd742a04dc41572c1ca
Stable URL of this page
https://metraipolis.com/documento/dc_4bbb373f9896

How to cite

Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease — Europe PMC PMID:41990093 — Europe PMC (en), https://europepmc.org/article/MED/41990093 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bbb373f9896 (Metraipolis archive dc_4bbb373f9896, sha256 954f2490f35448aa8e46882f0b3ba1fc5a104584c4d93dd742a04dc41572c1ca)
BibTeX
@misc{dc4bbb373f9896,
  title = {Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease — Europe PMC PMID:41990093},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41990093},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bbb373f9896; sha256 954f2490f35448aa8e46882f0b3ba1fc5a104584c4d93dd742a04dc41572c1ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41990093. Agents can read the archived copy with the MCP tool read_document.